2025 · 2nd Quarter (Apr 1 - June 30)

THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES)

Filed by BANNER PUBLIC AFFAIRS, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 22, 2025
Income: $20,000.00
Expenses: Not reported
Registrant: BANNER PUBLIC AFFAIRS, LLC
Client: THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES)
Filing UUID: e0dfe20d-e307-4ee6-871b-7749218fff96
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

Pharmacy issues related to TRICARE; H.R. 4016 - Department of Defense Appropriations, FY2026; H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Literal federal measure citations: H.R. 4016, H.R. 3838, S. 2296

HCR · Health Issues

S.526 - Pharmacy Benefit Manager Transparency Act of 2025; S. 1339 - Pharmacy Benefit Reform Act (118th Congress); S. 1542/H.R. 2214 - DRUG Act (118th Congress); S. 1038/H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 (118th Congress); S. 5503/H.R. 10362 - PBM Act of 2024 (118th Congress).

Literal federal measure citations: S.526, S. 1339, S. 1542, H.R. 2214, S. 1038, H.R. 1613, S. 5503, H.R. 10362

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.